MODULATORS OF GLUCOSE HOMEOSTASIS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
申请人:Chen Xin
公开号:US20110160222A1
公开(公告)日:2011-06-30
Aryl 119 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
提供了Aryl 119激动剂。这些化合物对于治疗代谢性疾病,包括II型糖尿病和与血糖控制不佳相关的疾病非常有用。